In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International journal of pharmaceutics

• Publication date

  2006-08-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJPHARM.2006.03.009PMID 16624508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Absorption Enhancement of Salmon Calcitonin

  2004cited by this paper
• Preservation of post-transplant lung function with aerosol cyclosporin

  2004cited by this paper
• Labiris NR, Dolovich MB. Pulmonary drug delivery: part II. the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

  2004cited by this paper
• Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules.

  2004cited by this paper
• Effects of Hydrophilic Cyclodextrins on Aggregation of Recombinant Human Growth Hormone

  2004cited by this paper
• Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.

  2003cited by this paper
• Pulmonary deposition of a budesonide/γ-cyclodextrin complex in vitro

  2003cited by this paper
• A cyclosporin A/maltosyl‐α‐cyclodextrin complex for inhalation therapy of asthma

  2003cited by this paper
• Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.

  2003cited by this paper
• Pulmonary deposition of a budesonide/gamma-cyclodextrin complex in vitro.

  2003cited by this paper
• Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.

  2003cited by this paper
• Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin

  2003cited by this paper
• A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma.

  2003cited by this paper
• Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI.

  2002cited by this paper
• The lung as a route for systemic delivery of therapeutic proteins and peptides

  2001cited by this paper
• Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols: the in-vitro deposition and toxicity studies of the complexes.

  2001cited by this paper
• Pulmonary Drug Delivery from the Taifun Dry Powder Inhaler Is Relatively Independent of the Patient's Inspiratory Effort

  2000cited by this paper
• Particulate Interactions in Dry Powder Formulations for Inhalation

  2000cited by this paper
• Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.

  1999cited by this paper
• Cyclodextrins in peptide and protein delivery.

  1999cited by this paper
• alpha-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins.

  1999cited by this paper
• Properties and the inclusion behavior of 6-O-alpha-D-galactosyl- and 6-O-alpha-D-mannosyl-cyclodextrins.

  1999cited by this paper
• Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution.

  1999cited by this paper
• Beclomethasone/cyclodextrin inclusion complex for dry powder inhalation

  1999cited by this paper
• Enzymatic Degradation of Luteinizing Hormone Releasing Hormone (LHRH)/[D-Ala6]-LHRH in Lung Pneumocytes

  1998cited by this paper
• Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery

  1997cited by this paper
• Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.

  1997cited by this paper
• Effect of cyclosporin A on the allergen-induced late asthmatic reaction.

  1997cited by this paper
• Pulmonary absorption enhancement of peptides by absorption enhancers and protease inhibitors

  1996cited by this paper
• Cyclodextrins : Useful excipients for oral peptide administration ?

  1996cited by this paper
• Pulmonary delivery of therapeutic peptides and proteins

  1994cited by this paper
• Cyclodextrins in Pharmacy

  1993cited by this paper
• Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs

  1991cited by this paper
• Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of β-, DM-β- and HP-β-cyclodextrins in rabbits

  1991cited by this paper
• Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.

  1991cited by this paper
• Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis.

  1991cited by this paper
• British Pharmaceutical Conference Science Award Lecture 1986: Order out of chaos

  1987cited by this paper
• Order out of chaos

  1984cited by this paper
• Phase solubility techniques

  1965cited by this paper
• Advances in analytical chemistry and instrumentation

  1960cited by this paper

• Inhaled Biologics: Overcoming Challenges and Recent Advances.

  2026cites this paper
• Dry Powder Inhalers for Delivery of Synthetic Biomolecules

  2025cites this paper
• Highly Drug-Loaded Nanoaggregate Microparticles for Pulmonary Delivery of Cyclosporin A

  2024cites this paper
• Formulation and Evaluation of Favipiravir Proliposomal Powder for Pulmonary Delivery by Nebulization

  2022cites this paper
• [Design and Biopharmaceutical Evaluations of Peptide-loaded Inhalable Formulation to Control Pharmacokinetic Behavior].

  2020cites this paper
• Challenges for pulmonary delivery of high powder doses

  2018cites this paper
• FORMULATION, OPTIMIZATION, AND CHARACTERIZATION OF BIOCOMPATIBLE INHALABLE D-CYCLOSERINE-LOADED ALGINATE-CHITOSAN NANOPARTICLES FOR PULMONARY DRUG DELIVERY

  2016cites this paper
• Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins.

  2015cites this paper
• Respirable nanocarriers as a promising strategy for antitubercular drug delivery.

  2014cites this paper
• Drug Solubilization and Stabilization by Cyclodextrin Drug Carriers

  2013cites this paper
• Inhaled proteins: challenges and perspectives.

  2013cites this paper
• Comparative evaluation of cyclosporine A/HPβCD-incorporated PLGA nanoparticles for development of effective ocular preparations

  2012cites this paper
• Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers.

  2012cites this paper
• Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes

  2011cites this paper
• Transmucosal and Ocular Drug Delivery

  2011cites this paper
• Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.

  2010cites this paper
• Methyl-beta-cyclodextrin restores the structure and function of pulmonary surfactant films impaired by cholesterol.

  2010cites this paper
• Formulation and Evaluation of a Protein-loaded Solid Dispersions by Non-destructive Methods

  2010cites this paper
• Sparing methylation of beta-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro.

  2009cites this paper
• New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

  2009cites this paper
• Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo.

  2008cites this paper
• Solid lipid nanoparticles for pulmonary delivery of insulin.

  2008cites this paper
• Pulmonary drug delivery: Implication for new strategy for pharmacotherapy for neurodegenerative disorders.

  2008cites this paper
• New highly effective dry powder tobramycin formulations for inhalation in the treatment of cystic fibrosis

  2008cites this paper
• Advanced delivery of Ciclosporin A: present state and perspective

  2007cites this paper
• Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.

  2007cites this paper